The Latest
-
Congress eyes tackling healthcare consolidation
“I think there’s common ground here,” one Republican congressman said Wednesday during a House Budget Committee hearing. Squaring up against healthcare monopolies would be a major pivot for the GOP.
-
AdvaMed leaders on tariffs, MDUFA and wearables
AdvaMed CEO Scott Whitaker and Mick Farrell, new board chair of the trade group, weighed in on important issues for the medtech industry one year into the Trump administration.
-
Integra recalls wound and burn devices amid reports of serious injuries
Packaging failures could lead to breaches in the sterile barrier and patient infections.
-
Abbott posts Q4 sales below expectations
Pricing challenges in Abbott’s nutrition business and lower than expected sales of continuous glucose monitors drove down the company’s shares.
-
Amazon launches health AI chatbot for One Medical members
The assistant, which can answer health questions and help schedule appointments, comes on the heels of other health-focused AI tools from OpenAI and Anthropic.
-
ECRI names misuse of AI chatbots as top health tech hazard for 2026
The nonprofit said technologies like ChatGPT have suggested incorrect diagnoses, invented body parts and otherwise provided information that could lead to harm.
-
J&J’s cardiovascular business boosts medtech growth in 2025
Cardiovascular was the only business unit to grow by double digits last year, helping to fuel the overall medical device business to top $33 billion.
-
Retrieved from Anteris Technologies Global on January 21, 2026
Medtronic to buy up to $90M stake in heart valve developer Anteris
Medtronic’s investment is contingent on Anteris completing a proposed $200 million public stock offering.
-
BVI appoints Jim Hollingshead as CEO
Hollingshead, the former CEO of Insulet, will lead BVI as it uses a $1 billion financing to support its global eye care business.
-
3 takeaways from Boston Scientific’s $14.5B Penumbra deal
Penumbra is expected to give Boston Scientific more of a presence in the vascular surgery market, with little overlap between the two companies’ products.
-
Abbott gets Europe’s CE mark for dual ablation catheter
The device can deliver both radiofrequency energy and pulsed field ablation to treat heart arrhythmias.
-
Boston Scientific recalls stent over issue linked to 3 deaths
The company said the deaths were associated with off-label or investigational use of the device.
-
Intuitive says general surgery, acute care fuel US robot momentum
CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving greater utilization than the earlier Xi model.
-
STAAR CEO exits after company rejects Alcon buyout
An activist investor has reshaped the board, securing the departures of STAAR’s CEO and chair.
-
Boston Scientific to acquire Penumbra for $14.5B
With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.
-
Deep Dive
5 topics to watch as MDUFA negotiations restart
The next Medical Device User Fee Amendments, which will set how much the FDA can raise from the industry in fees over a five-year period, are expected to go to Congress this year.
-
Trump unveils healthcare affordability plan
The “Great Healthcare Plan” is vague, but would send money directly to ACA enrollees and entrench Trump’s drug pricing deals.
-
Trump issues 25% tariffs on narrow range of semiconductors
The levies, effective Jan. 15, do not cover products used for data centers and consumer applications, per a proclamation signed Wednesday.
-
Medtronic inks deal to build brain computer interface into surgical system
Medtronic will integrate Precision Neuroscience’s Layer 7 cortical interface with its StealthStation surgical navigation system.
-
Digital health funding increases in 2025, spurred by AI: report
Startups raised $14.2 billion last year, the highest funding total since 2022. Health AI companies collected 54% of total funding, according to Rock Health.
-
Boston Scientific gains FDA’s OK for new PFA catheter
The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain its electrophysiology market share, one analyst said.
-
Smith & Nephew to acquire Integrity Orthopaedics for up to $450M
The company has committed the cash, half of which it is paying upfront, to buy Integrity Orthopaedics for its rotator cuff repair system.
-
Boston Scientific to buy incontinence device maker Valencia
The deal would set up Boston Scientific to compete with Medtronic in the market for neuromodulation devices that work by stimulating the tibial nerve.
-
Medtronic gets FDA clearance for smart insulin pen app
The app pairs Medtronic’s smart insulin pens with a sensor made by Abbott.
-
Inspire appoints Matt Osberg as CFO
While Osberg joins Inspire without prior medtech experience, CEO Tim Herbert says the new CFO can help take the company “to the next level.”